TRex Bio, Inc.

Healthcare · Biotechnology · United States

Last price 13.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 363.99M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

TRex Bio, Inc. develops immunoregulatory biologics for autoimmune and inflammatory diseases in United States and Internationally. The company operates the Deep Biology Platform, a drug discovery and design platform that integrates tissue-level insights into human biology and treg function to identify and characterize therapeutic targets, using computational mapping, which uses in silico tools and a human tissue bank and atlas of human treg gene expression to identify pathways in tissue immune regulation; the Treg Atlas, which recreates tissue s...